-
Recent Posts
Archives
Categories
Meta
Monthly Archives: November 2011
Thoughts, six months later
Whoa, what happened out in UC-Davis? Pepper spraying students protesting peacefully? Not right. OK, back to some fun. A half-year. Six-months. 184 days. More grey hairs. This has been a fun experiment. Once a week (or so), I jot down … Continue reading
Bittersweet hESCs, $GERN
Bittersweet to see Geron ($GERN) drop their embryonic stem cell (ESC) program. On one hand, the science is pretty cool and much has been learned with $GERN leading the way. But, on the other, the bar for safety and efficacy … Continue reading
Posted in Uncategorized
Tagged $GERN, biotech, embryonic stem cells, Geron, hESC, strategy
1 Comment
Don’t feel like chicken? ($NVAX)
We wrap up an interesting week with thanks to all the veterans for their dedication and service. No where better to live than here in the US. And an interesting week it has been. While earnings continue to be reported, … Continue reading
No, not inhibited ($INHX)
This why biotech is fun. Beginning yesterday and continuing through the weekend, many investors’ eyes will be focused on The Liver Meeting, being held in San Francisco, with the latest advances in liver disease being shared and discussed. The first … Continue reading
Posted in Research, Update
Tagged $IDIX, $INHX, $VRUS, biotech, DAA, HCV, Idenix, Inhibitex, NS5b, Pharmasset, polymerase inhibitor
Leave a comment